EN
中文 EN
  • 630+

    Peer-reviewed Articles

    UP TO 2025.04

  • 4240+

    lmpact Factor

  • 25+

    Tumor Types Involved

J Immunother Cancer. | 29-Nov-2024
Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC

Non-squamous NSCLC

Learn More
Sci China Life Sci. | Jan-2025
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials

OncoCompassⓇ Plus (520-gene Panel, ctDNA) | NSCLC

Learn More
Cancer Cell | 09-Sep-24
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer

OncoCompassⓇ Plus (520-gene panel, ctDNA) | NSCLC

Learn More
eClinical Medicine丨03-Aug-24
Development and validation of an integrated system for lungcancer screening and post-screening pulmonary nodulesmanagement: a proof-of-concept study (ASCEND-LUNG)
OncoCompassⓇ Target (168-gene panel, ctDNA) & BNR's Methylation-based Technology | Lung Cancer
Learn More
Cell Reports Medicine丨18-Jun-24
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: phase 2 trial interim results (NEOTIDE/CTONG2104)
CanCatch Tumor-Informed MRD | NSCLC
Learn More
1 2 3 4 5 6 7 8 9 10 ...
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."